SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,625,261 | +74.5% | 21,657 | +64.8% | 1.10% | +63.4% |
| Q2 2023 | $1,504,793 | +84.7% | 13,140 | +122.3% | 0.67% | +71.4% |
| Q1 2023 | $814,713 | -12.0% | 5,911 | +2.4% | 0.39% | -44.8% |
| Q2 2020 | $926,000 | +202.6% | 5,774 | +84.5% | 0.71% | +91.4% |
| Q1 2020 | $306,000 | +23.4% | 3,129 | +91.5% | 0.37% | +136.3% |
| Q2 2019 | $248,000 | -39.8% | 1,634 | -52.7% | 0.16% | -51.4% |
| Q1 2019 | $412,000 | +82.3% | 3,454 | +67.0% | 0.32% | +85.6% |
| Q4 2018 | $226,000 | -17.2% | 2,068 | +22.4% | 0.17% | -26.6% |
| Q3 2018 | $273,000 | -53.0% | 1,689 | -78.5% | 0.24% | -46.0% |
| Q1 2018 | $581,000 | -47.8% | 7,840 | -60.8% | 0.44% | -35.0% |
| Q4 2017 | $1,112,000 | – | 19,982 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |